Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

47%

9 trials in Phase 3/4

Results Transparency

0%

0 of 19 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
9(47.4%)
Phase 1
5(26.3%)
Phase 2
5(26.3%)
19Total
Phase 3(9)
Phase 1(5)
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT03626948Phase 3Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Role: lead

NCT03801980Phase 3Completed

Phase 3 Study of SK-1403

Role: lead

NCT03226171Phase 2Completed

Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism

Role: lead

NCT03218501Phase 2Completed

A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

Role: lead

NCT03116191Phase 2Completed

Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

Role: lead

NCT02327754Phase 2Completed

Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout

Role: lead

NCT02846181Phase 1Completed

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1405

Role: lead

NCT02878096Phase 1Completed

Bioavailability of [14C]-SK-1404 ADME & IV Microtracer Study

Role: lead

NCT02650076Phase 1Completed

A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects

Role: lead

NCT02100267Phase 3Completed

A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma

Role: lead

NCT00308477Phase 1Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Role: lead

NCT00308542Phase 1Completed

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Role: lead

NCT00334503Phase 3Completed

Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Role: lead

NCT00334399Phase 3Completed

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Role: lead

NCT00532506Phase 2Completed

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Role: lead

NCT00213122Phase 3Completed

Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

Role: lead

NCT00380822Phase 3Completed

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Role: lead

NCT00213109Phase 3Completed

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

Role: lead

NCT00213070Phase 3Completed

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment

Role: lead

All 19 trials loaded